BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Yang M, Yin J, Li P, Zeng S, Zheng G, He Z, Liu H, Wang Q, Zhang F, Chen D. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling. Cell Commun Signal 2022;20:92. [PMID: 35715860 DOI: 10.1186/s12964-022-00888-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao ZX, Zhang ZS, Qin J, Zhang MZ, Cao JL, Li YY, Wang MQ, Hou LL, Fang D, Xie SQ. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma. Phytomedicine 2023;112:154715. [PMID: 36821999 DOI: 10.1016/j.phymed.2023.154715] [Reference Citation Analysis]
2 Mirshahidi S, Yuan IJ, Simental A, Lee SC, Peterson NR, Andrade Filho PA, Murry T, Duerksen-hughes P, Yuan X. Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid Cancer. IJMS 2023;24:5471. [DOI: 10.3390/ijms24065471] [Reference Citation Analysis]
3 Desai N, Hasan U, K J, Mani R, Chauhan M, Basu SM, Giri J. Biomaterial-based Platforms for Modulating Immune Components against Cancer and Cancer Stem Cells. Acta Biomater 2023:S1742-7061(23)00130-7. [PMID: 36907233 DOI: 10.1016/j.actbio.2023.03.004] [Reference Citation Analysis]
4 May AM, Batoon L, McCauley LK, Keller ET. The Role of Tumor Epithelial-Mesenchymal Transition and Macrophage Crosstalk in Cancer Progression. Curr Osteoporos Rep 2023. [PMID: 36848026 DOI: 10.1007/s11914-023-00780-z] [Reference Citation Analysis]
5 Zwager MC, Bense R, Waaijer S, Qiu SQ, Timmer-Bosscha H, de Vries EGE, Schröder CP, van der Vegt B. Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis. Breast Cancer Res Treat 2023;198:11-22. [PMID: 36622544 DOI: 10.1007/s10549-022-06859-y] [Reference Citation Analysis]
6 Kim S, Choi I, Han IH, Bae H. Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer. Int J Mol Sci 2022;23. [PMID: 36555393 DOI: 10.3390/ijms232415751] [Reference Citation Analysis]
7 Furukawa N, Stearns V, Santa-Maria CA, Popel AS. The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert Opin Ther Targets 2022;26:1041-56. [PMID: 36657483 DOI: 10.1080/14728222.2022.2170779] [Reference Citation Analysis]
8 Wang J, Yang Y, Du B. Clinical Characterization and Prognostic Value of TPM4 and Its Correlation with Epithelial–Mesenchymal Transition in Glioma. Brain Sciences 2022;12:1120. [DOI: 10.3390/brainsci12091120] [Reference Citation Analysis]